Teladoc stock kpis
Want to see TDOC full AI Analyst Report?
Revenue by Segment
Teladoc reported revenue by segment of $605.10M in Q3 2026, down 0.3% from Q2 2026 and down 3.4% year over year. The highest value was $660.53M in Q4 2023.
Revenue split across Teladoc’s business lines—virtual urgent care, mental health, chronic care, payer/employer contracts, etc.—highlighting which services drive growth and margins. Segment trends reveal where the company is gaining traction or facing pricing pressure.
The business mix has materially shifted: Visit Fees vanish after 2022 (a model/reclassification inflection), Access Fees have softened from their peak, and the “Other” bucket has grown rapidly to become the primary revenue driver — a structural move toward newer, higher‑value lines. Management’s commentary confirms Integrated Care and product/AI initiatives are underpinning margin expansion, while BetterHelp’s cash‑pay decline and insurance conversion constraints are the main near‑term drag; mix improvement supports margins, but BetterHelp execution risk keeps consolidated revenue under pressure.
TDOC Revenue by Segment
| Period | Other | Access Fees | Visit Fees | Total |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $138.38M | $466.72M | $0.00 | $605.10M |
| Q2 2026Jun 30, 2026 | $132.71M | $474.21M | $0.00 | $606.93M |
| Q1 2026Mar 31, 2026 | $129.19M | $484.65M | $0.00 | $613.85M |
| Q4 2025Dec 31, 2025 | $120.67M | $521.60M | $0.00 | $642.27M |
| Q3 2025Sep 30, 2025 | $105.53M | $520.91M | $0.00 | $626.44M |
| Q2 2025Jun 30, 2025 | $108.20M | $523.70M | $0.00 | $631.90M |
| Q1 2025Mar 31, 2025 | $103.63M | $525.74M | $0.00 | $629.37M |
| Q4 2024Dec 31, 2024 | $97.37M | $543.12M | $0.00 | $640.49M |
| Q3 2024Sep 30, 2024 | $85.23M | $555.27M | $0.00 | $640.51M |
| Q2 2024Jun 30, 2024 | $82.80M | $559.65M | $0.00 | $642.44M |
| Q1 2024Mar 31, 2024 | $88.96M | $557.17M | $0.00 | $646.13M |
| Q4 2023Dec 31, 2023 | $86.61M | $573.92M | $0.00 | $660.53M |
| Q3 2023Sep 30, 2023 | $78.17M | $582.07M | $0.00 | $660.24M |
| Q2 2023Jun 30, 2023 | $76.75M | $575.66M | $0.00 | $652.41M |
| Q1 2023Mar 31, 2023 | $78.37M | $550.87M | $0.00 | $629.24M |
| Q4 2022Dec 31, 2022 | $84.04M | $553.67M | $0.00 | $637.71M |
| Q3 2022Sep 30, 2022 | $5.76M | $540.08M | $65.57M | $611.40M |
| Q2 2022Jun 30, 2022 | $6.92M | $518.73M | $66.73M | $592.38M |
| Q1 2022Mar 31, 2022 | $6.08M | $491.34M | $67.93M | $565.35M |
| Q4 2021Dec 31, 2021 | $14.10M | $478.80M | $68.92M | $561.82M |
| Q3 2021Sep 30, 2021 | $10.10M | $451.58M | $59.98M | $521.66M |
| Q2 2021Jun 30, 2021 | $9.77M | $434.04M | $59.33M | $503.14M |
| Q1 2021Mar 31, 2021 | $11.06M | $382.11M | $60.51M | $453.67M |
| Q4 2020Dec 31, 2020 | $14.10M | $312.17M | $57.05M | $383.32M |
| Q3 2020Sep 30, 2020 | $11.15M | $226.62M | $51.04M | $288.81M |
| Q2 2020Jun 30, 2020 | $0.00 | $182.17M | $58.86M | $241.03M |
| Q1 2020Mar 31, 2020 | $0.00 | $137.05M | $43.75M | $180.80M |
| Q4 2019Dec 31, 2019 | $0.00 | $126.98M | $29.51M | $156.49M |
| Q3 2019Sep 30, 2019 | $0.00 | $119.13M | $18.84M | $137.97M |
| Q2 2019Jun 30, 2019 | $0.00 | $111.24M | $19.04M | $130.28M |
| Q1 2019Mar 31, 2019 | $0.00 | $105.95M | $22.62M | $128.57M |
| Q4 2018Dec 31, 2018 | $0.00 | $102.70M | $20.04M | $122.74M |
| Q3 2018Sep 30, 2018 | $0.00 | $96.56M | $14.40M | $110.96M |
| Q2 2018Jun 30, 2018 | $0.00 | $79.80M | $14.76M | $94.56M |
| Q1 2018Mar 31, 2018 | $0.00 | $71.70M | $17.90M | $89.60M |
| Q4 2017Dec 31, 2017 | $0.00 | $65.40M | $11.80M | $77.20M |
| Q3 2017Sep 30, 2017 | $0.00 | $60.30M | $8.30M | $68.60M |
| Q2 2017Jun 30, 2017 | $0.00 | $37.50M | $7.10M | $44.60M |
| Q1 2017Mar 31, 2017 | $0.00 | $34.30M | $8.60M | $42.90M |

